The rise of digital and patient-led medicine, the waning of many blockbuster medicines, more niche treatments and a keener search for value from payers are just some of the factors driving leading pharma
marketeers to establish leaner and more responsive approaches to marketing. We will show you how in this latest whitepaper.

Download your copy of the content now >>>

From this whitepaper, you will learn:

  • Why agility is the future of pharma marketing
  • How companies like Pfizer and Astrazeneca embraced agility to
    great success
  • How a ‘design thinking’ approach has been implemented
  • The right metrics to measure your new approach

And much more.

Download your copy of the content now >>>

Access this paper and you’ll receive insights from:

  • Emilie Bugeat-Toussaint, Senior Director, Commercial Operations, Pfizer
  • Chris Cullmann, Head of Digital, Ogilvy CommonHealth Worldwide
  • Mark Mallon, EVP, Global Product and Portfolio Strategy, AstraZeneca
  • Jeremy Mittler, VP, Industry Solutions, Crossix
  • Bob Pearson, Vice Chairman and Chief Innovation Officer, W20 Group
  • Morten Remmer, Chief Growth Officer and Head, LEO Innovation Lab Incubator
  • Edward Scotcher, Chief Operating Officer, Agility in Mind
  • Shail Thaker, Senior Partner, McKinsey
  • Julian Tompkins, President, Commercial and Clinical, Ashfield.

Download your copy of the content now >>>

Kind regards,

Bolder, faster, better

eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

Terms and conditions | Privacy Policy

Find out how pharma marketing leaders are implementing agile marketing

We'd love to keep in touch